Rubric Capital Management (New York)’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-61,280
| Closed | -$1.65M | – | 65 |
|
|
2023
Q2 | $1.65M | Sell |
61,280
-234,790
| -79% | -$6.3M | 0.07% | 59 |
|
|
2023
Q1 | $17.3M | Sell |
296,070
-256,905
| -46% | -$15M | 0.45% | 46 |
|
|
2022
Q4 | $28.2M | Buy |
552,975
+286,967
| +108% | +$14.6M | 1.23% | 27 |
|
|
2022
Q3 | $21.8M | Sell |
266,008
-27,325
| -9% | -$2.24M | 1.1% | 32 |
|
|
2022
Q2 | $19.8M | Buy |
293,333
+52,837
| +22% | +$3.57M | 1.04% | 31 |
|
|
2022
Q1 | $26.6M | Buy |
240,496
+55,000
| +30% | +$6.08M | 0.96% | 26 |
|
|
2021
Q4 | $17.9M | Sell |
185,496
-39,555
| -18% | -$3.82M | 0.85% | 37 |
|
|
2021
Q3 | $19.6M | Sell |
225,051
-58,496
| -21% | -$5.11M | 0.55% | 36 |
|
|
2021
Q2 | $43.9M | Buy |
+283,547
| New | +$43.9M | 2.76% | 16 |
|